Skip to main content
. 2016 Mar 22;7:101. doi: 10.3389/fimmu.2016.00101

Figure 5.

Figure 5

Antibody and IL-18 synergism in response to H3N2. PBMCs were stimulated for 18 h in vitro Med (medium alone), 5, 10, and 50 ng/ml IL-18 with or without 1 μg/ml inactivated influenza virus H3N2. Responses were measured as the percentage of NK cells expressing surface CD107a (A), surface CD25 (B), or intracellular IFN-γ (C) (n = 7–8, data from one experiment). Box plots show the 5th to 95th percentile range. Data were analyzed with paired Wilcoxon signed-rank tests. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05.